Williams Cancer Institute

Unveiling RRx-001: A Game-Changing Molecule in Cancer Treatment

In the relentless pursuit of innovative cancer treatments, a groundbreaking discovery has emerged in the form of RRx-001, a small molecule with profound potential. Delving into this remarkable development, a study titled “Discovery of RRx-001, a Myc and CD47 Downregulating Small Molecule with Tumor Targeted Cytotoxicity and Healthy Tissue Cytoprotective Properties in Clinical Development” published […]